tiprankstipranks
Advertisement
Advertisement
Immunotech Biopharm Settles 2023 Bonds via RMB300 Million Convertible Issue
PremiumCompany AnnouncementsImmunotech Biopharm Settles 2023 Bonds via RMB300 Million Convertible Issue
2M ago
Immunotech Biopharm to Issue New Convertible Bonds to Settle 2023 Notes
Premium
Company Announcements
Immunotech Biopharm to Issue New Convertible Bonds to Settle 2023 Notes
2M ago
Immunotech Biopharm Subsidiary Signs RMB9.75 Million Cell Therapy Service Deal With Tasly
Premium
Company Announcements
Immunotech Biopharm Subsidiary Signs RMB9.75 Million Cell Therapy Service Deal With Tasly
2M ago
Immunotech Biopharm Ltd Announces Board Composition and Committee Roles
PremiumCompany AnnouncementsImmunotech Biopharm Ltd Announces Board Composition and Committee Roles
6M ago
Immunotech Biopharm Announces Rights Issue to Raise Up to HK$307.84 Million
Premium
Company Announcements
Immunotech Biopharm Announces Rights Issue to Raise Up to HK$307.84 Million
7M ago
Immunotech Biopharm Ltd Announces Trading Halt Pending Rights Issue Announcement
Premium
Company Announcements
Immunotech Biopharm Ltd Announces Trading Halt Pending Rights Issue Announcement
7M ago
Immunotech Biopharm Ltd Sets Terms for Nomination Committee
PremiumCompany AnnouncementsImmunotech Biopharm Ltd Sets Terms for Nomination Committee
9M ago
Immunotech Biopharm Ltd Announces Board Composition and Committee Roles
Premium
Company Announcements
Immunotech Biopharm Ltd Announces Board Composition and Committee Roles
10M ago
Immunotech Biopharm Announces Executive Resignation Amid Governance Dispute
Premium
Company Announcements
Immunotech Biopharm Announces Executive Resignation Amid Governance Dispute
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100